Skip to main content

Importance of intra-therapy single-photon emission tomographic imaging in calculating tumour dosimetry for a lymphoma patient

Abstract

The dosimetry for two, similarly sized tumours in a lymphoma patient being treated with non-bone marrow ablative, monoclonal antibody therapy is reported. The 45-year-old man was infused with 2.48 GBq (67 mCi) of131I-labelled MB-1. Prior to therapy, a time series of diagnostic conjugate-view images and a radionuclide transmission scan were obtained and processed to obtain time-activity curves. Starting 2 days after the therapeutic infusion of radioactivity, a second conjugate-view time series was obtained. At that time, a quantitative single-photon emission tomography (SPET) acquisition was also carried out. Pre- and post-therapy X-ray computed tomography scans demonstrated a percentage reduction in volume for the right tumour which was 3.8 times that for the left tumour. In contrast, diagnostic conjugate views by themselves estimated the absorbed dose to be the same for the two tumours. Addition of therapy conjugate-view data increased the right-over-left ratio but only to 1.22. Normalizing either time-activity series by the intra-therapy SPET results increased the ratio to greater than 1.5. We assume here that a differential dose is correct according to the differential tumour shirnkage. One can further assume that the largest ratio corresponds most certainly to the most accurate dosimetric method. Other assumptions are possible. While additional study is essential, data from this patient suggest that the preferred dosimetric method is intra-therapy SPET normalization of either time series.

This is a preview of subscription content, access via your institution.

References

  • Bigler RE (1989) “Final Report” for 3 year NIH National Cancer Institute radiation research program contract (contract no. N01-CM37565). Dose calculations for cancer therapy using radioactively labeled antibodies to a tumor-associated and/or tumor-specific antigens. Cornell University Medical College, New York, pp 63–150

    Google Scholar 

  • Doherty P, Schwinger R, King M, Gionet M (1985) Distribution and dosimetry of indium-111 labeled F(ab′)2 fragments in humans. Fourth international radiopharmaceutical dosimetry symposium, Nov 5–8, 1985, Oak Ridge, TN, CONF-851113(DE86010102)

  • Eary JF, Appelbaum FL, Durack L, Brown P (1989) Preliminary validation of opposing view method for quantitative gamma camera imaging. Med Phys 16(3):382–387

    Article  PubMed  Google Scholar 

  • Eary JF, Press OW, Badger CC, Durack LD, Richter KY, Addison SJ, Krohn KA, Fisher DR, Porter BA, Williams DL, Martin PJ, Appelbaum FR, Levy R, Brown SL, Miller RA, Nelp WB, Bernstein ID (1990) Imaging and treatment of B-cell lymphoma. J Nucl Med 31:1257–1268

    PubMed  Google Scholar 

  • Kallman RF (ed) (1987) Rodent tumor models. Pergamon, New York

    Google Scholar 

  • Koral KF, Wang X, Sisson JC, Botti J, Meyer L, Mallette S, Glazer GM, Adler RS (1989) Calculating radiation absorbed dose for pheochromocytoma tumors in 131-I MIBG therapy. Int J Radiat Oncol Biol Phys 17:211–218

    PubMed  Google Scholar 

  • Koral KF, Swailem FM, Buchbinder S, Clinthorne NH, Rogers WL, Tsui BMW (1990a) SPET dual-energy-window Compton correction: scatter multiplier required for quantification. J Nucl Med 31:90–98

    PubMed  Google Scholar 

  • Koral KF, Swailem FM, Clinthorne NH, Rogers WL, Tsui BMW (1990b) Dual-window Compton-scatter correction in phantoms: errors and multiplier dependence on energy. J Nuel Med 31:798–799 (abstr)

    Google Scholar 

  • Link M, Bindl J, Meeker TC, Carswell C, Doss CA, Warnke RA, Levy R (1986) A unique antigen on mature B cells defined by a monoclonal antibody. J Immunol 137:3013–3018

    PubMed  Google Scholar 

  • Nickoloff EL, Perman WH, Esser PD, Bashist B, Alderson PO (1981) Left ventricular volume: physical basis for attenuation corrections in radionuclide determinations. Radiology 152:511–515

    Google Scholar 

  • Press OW, Eary JF, Badger CC, Martin PJ, Appelbaum FR, Levy R, Miller R, Brown S, Nelp WB, Krohn KA, Fisher D, DeSantes K, Porter B, Kidd P, Thomas ED, Bernstein ID (1989) Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody. J Clin Oncol 7(8):1027–1038

    PubMed  Google Scholar 

  • Tsui BMW, Gullberg GT, Edgerton ER, Ballard JG, Perry JR, McCartney WH, Berg J (1989) Correction of nonuniform attenuation in cardiac SPET imaging. J Nucl Med 30:497–507

    PubMed  Google Scholar 

  • Wahl R, Fig L, Zasadny K, Koral K, Francis I, Miller R, Buchsbaum D, Kaminski M (1990) Radioimmunotherapy of B-cell lymphoma with 1131 MB-1 monoclonal antibody. J Nucl Med 31:852 (abstr)

    Google Scholar 

  • Zanzonico P, Bigler R, Sgouros G, Strauss A, Becker D (1989) Quantitative SPET in radiation dosimetry. Semin Nucl Med XIX:47–61

    Google Scholar 

  • Zasadny KR, Koral KF, Swailem FM, Rogers WL (1990) Deadtime of an anger camera in dual-energy-window-acquisition mode. J Nucl Med 31:759–760 (abstr)

    Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Koral, K.F., Zasadny, K.R., Swailem, F.M. et al. Importance of intra-therapy single-photon emission tomographic imaging in calculating tumour dosimetry for a lymphoma patient. Eur J Nucl Med 18, 432–435 (1991). https://doi.org/10.1007/BF02258433

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02258433

Key words

  • Tumour dosimetry
  • Single-photon emission tomography (SPET) quantification
  • Lymphoma
  • Monoclonal antibody
  • Radionuclide therapy